comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 19:39:24 - browse：841

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Search called off for baby washed away in Pennsylvania flash flood

WSS

A new crop of companies is reshaping the health data economy

Eli Lilly to pay $200M for Beam’s stake in gene

Readout Newsletter: XBI biotech index, Akero Therapeutics

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

What it's like to live with paralysis for one psychologist

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

hotspot

comprehensive

hotspot

How one medical school became remarkably diverse

Senate panel puts off hardest PBM reforms for another day

Apple is now the first public company to be valued at $3 trillion

First Opinion Podcast: How to protect health care in times of war

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Paying for Covid pills will soon shift to insurers

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chimpanzees, like humans and whales, get menopause: Study

Jerome Adams on the need for new antivirals for Covid

FDA has safety concerns on CRISPR

entertainment

First Opinion Podcast: How to protect health care in times of war

Senate panel to vote on hospitals, PBMs, prisoner care

Former reverend arrested for allegedly killing 8

Roche’s Alnylam deal shows drug firms interested in heart drugs

Meta's Zuckerberg and Chan on track to put $50 billion into science

Telehealth options flood the market as retailers push virtual care

explore

focus

hotspot

leisure time